MicroRNA Biomarkers in Neurodegenerative Diseases and Emerging Nano-Sensors Technology
Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt
Standard
MicroRNA Biomarkers in Neurodegenerative Diseases and Emerging Nano-Sensors Technology. / Shah, Pratik; Cho, Seok Keun; Thulstrup, Peter Waaben; Bjerrum, Morten Jannik; Lee, Phil Hyu; Kang, Ju-Hee; Bhang, Yong-Joo; Yang, Seong Wook.
I: Journal of Movement Disorders, Bind 10, Nr. 1, 2017, s. 18-28.Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - MicroRNA Biomarkers in Neurodegenerative Diseases and Emerging Nano-Sensors Technology
AU - Shah, Pratik
AU - Cho, Seok Keun
AU - Thulstrup, Peter Waaben
AU - Bjerrum, Morten Jannik
AU - Lee, Phil Hyu
AU - Kang, Ju-Hee
AU - Bhang, Yong-Joo
AU - Yang, Seong Wook
PY - 2017
Y1 - 2017
N2 - MicroRNAs (miRNAs) are essential small RNA molecules (20–24 nt) that negatively regulate the expression of target genes at the post-transcriptional level. Due to their roles in a variety of biological processes, the aberrant expression profiles of miRNAs have been identified as biomarkers for many diseases, such as cancer, diabetes, cardiovascular disease and neurodegenerative diseases. In order to precisely, rapidly and economically monitor the expression of miRNAs, many cutting-edge nanotechnologies have been developed. One of the nanotechnologies, based on DNA encapsulated silver nanoclusters (DNA/AgNCs), has increasingly been adopted to create nanoscale bio-sensing systems due to its attractive optical properties, such as brightness, tuneable emission wavelengths and photostability. Using the DNA/AgNCs sensor methods, the presence of miRNAs can be detected simply by monitoring the fluorescence alteration of DNA/AgNCs sensors. We introduce these DNA/ AgNCs sensor methods and discuss their possible applications for detecting miRNA biomarkers in neurodegenerative diseases
AB - MicroRNAs (miRNAs) are essential small RNA molecules (20–24 nt) that negatively regulate the expression of target genes at the post-transcriptional level. Due to their roles in a variety of biological processes, the aberrant expression profiles of miRNAs have been identified as biomarkers for many diseases, such as cancer, diabetes, cardiovascular disease and neurodegenerative diseases. In order to precisely, rapidly and economically monitor the expression of miRNAs, many cutting-edge nanotechnologies have been developed. One of the nanotechnologies, based on DNA encapsulated silver nanoclusters (DNA/AgNCs), has increasingly been adopted to create nanoscale bio-sensing systems due to its attractive optical properties, such as brightness, tuneable emission wavelengths and photostability. Using the DNA/AgNCs sensor methods, the presence of miRNAs can be detected simply by monitoring the fluorescence alteration of DNA/AgNCs sensors. We introduce these DNA/ AgNCs sensor methods and discuss their possible applications for detecting miRNA biomarkers in neurodegenerative diseases
KW - miRNAs
KW - neurodegenerative diseases
KW - silver nanoclusters
KW - DNA sensor
U2 - 10.14802/jmd.16037
DO - 10.14802/jmd.16037
M3 - Review
C2 - 28122423
VL - 10
SP - 18
EP - 28
JO - Journal of Movement Disorders
JF - Journal of Movement Disorders
SN - 2005-940X
IS - 1
ER -
ID: 176369621